ProKidney Corp. Class A (PROK)
NASDAQ: PROKHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
At close: Oct 7, 4:00 PM ET · Delayed 15 min
After hours: 1.57 0.00%
PROK stock chart
Technical analysisKey statistics
All statistics- Market cap
- $626.72M
- EPS (TTM)
- -$0.55
- Dividend yield
- None
- 52-week range
- 1.30 – 3.48
- Day range
- 1.55 – 1.60
- Volume / Avg
- 823.86K / 1.31M
- Beta
- —
- Shares outstanding
- 208.93M
- Next earnings
- Nov 9, 2026
52-week range
PROK stock today
Shares of ProKidney (PROK) finished lower on Oct 7 at $1.57, a drop of 1.87% or $0.03 per share, versus the S&P 500's 0.22% decline. At this level, PROK sits near the bottom of its 52-week range of $1.30 to $3.48: 54.9% below the high and 20.8% above the low. ProKidney has posted a net loss over the last twelve months (EPS of -$0.55), so its P/E ratio is not meaningful.
ProKidney's next earnings report is expected on Nov 9, 2026.
Summary generated from market data by MetaCap's automated system. Methodology
About ProKidney
Company profile- Sector
- Health Care
- Industry
- Biotechnology: Biological Products (No Diagnostic Substances)
- Headquarters
- Winston-Salem, NC
- IPO year
- 2021
Earnings
Earnings history- Next report
- Nov 9, 2026
ProKidney peers
Health Care sector| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| AUTLAutolus Therapeutics plc ADR | 1.81 | +1.12% | $481.75M | vs PROK |
| ALLOAllogene Therapeutics Inc. | 1.43 | -2.05% | $494.05M | vs PROK |
| RGNXREGENXBIO Inc. | 7.60 | +1.95% | $501.37M | vs PROK |
| TECXTectonic Therapeutic Inc. | 22.71 | +1.34% | $443.97M | vs PROK |
| ENTXEntera Bio Ltd. | 2.51 | -0.79% | $436.32M | vs PROK |
| AGMBAgomAb Therapeutics NV ADR | 8.80 | -0.45% | $433.38M | vs PROK |
| EDITEditas Medicine Inc. | 2.75 | +0.73% | $422.35M | vs PROK |
| VALNValneva SE ADR | 5.87 | +0.17% | $556.61M | vs PROK |
Indexes, lists and sector
Largest Health Care stocks
ProKidney stock FAQ
What is ProKidney's stock price today?
PROK last traded at $1.57 as of Oct 7, 4:00 PM EDT, down 1.87% on the day. Prices are delayed at least 15 minutes.
When is ProKidney's next earnings date?
ProKidney is expected to report earnings on Monday, November 9, 2026.
What is the PROK 52-week high?
The 52-week high for PROK is $3.48 and the 52-week low is $1.30. The stock is currently 54.9% below its high.